Drug Database
Back to search

Japan· JP-2659708Q1070

ブテナフィン塩酸塩

A butenafine product containing ブテナフィン塩酸塩, registered in Japan by 東和薬品, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

On Japan’s NHI price listATC D01AE23

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedブテナフィン塩酸塩ATCD01AE23REGISTER NO.JP-2659708Q1070PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ブテナフィン塩酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Butenafine is registered in 3 of 19 countries.

Countries holding a registration under ATC D01AE23 (butenafine), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 2 of them publish a price we can compare per daily dose
Search butenafine products by name

Butenafine · ATC D01AE23

3 / 19 countries

  • Finlandprice
  • Japan
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ブテナフィン塩酸塩
Manufacturer
東和薬品
Country
Japan (JP)
ATC code
D01AE23
ATC class
Butenafine
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under D01AE23

Butenafine, as other registers publish it.

All butenafine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb3e2dd8-3ac6-478a-af9d-f58e26772c25
GET /v1/drugs/fb3e2dd8-3ac6-478a-af9d-f58e26772c25?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１％１ｍＬ",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2659708Q1070",
  "category": "外用薬",
  "price_yen": 14,
  "generic_name": "ブテナフィン塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "2659",
  "transitional_expiry": "R9.3.31まで"
}
API referenceMCP serverPlans

See everything about butenafine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console